In-Hospital Clinical Outcomes of Covid-19 Patients Treated with Oral Anticoagulants

Authors : Salih ŞAHİNKUŞ, Selcuk YAYLACI

Pages : 321-325

Doi:10.26453/otjhs.1235505

View : 57 | Download : 53

Publication Date : 2023-09-06

Article Type : Research Paper

Abstract :Objective: We aimed to investigate the effects of warfarin and new-generation oral anticoagulants on the prognosis of patients diagnosed with coronavirus disease 2019 insert ignore into journalissuearticles values(COVID-19);. Materials and Methods: Patients diagnosed with COVID-19 were divided into two groups depending on whether they were using warfarin or a new-generation oral anticoagulant. The types of chronic diseases, drugs used, hematological and biochemical parameters, and prognoses in each group were statistically analysed. Results: Twenty-three patients insert ignore into journalissuearticles values(37.1%); using warfarin and 39 insert ignore into journalissuearticles values(62.9%); patients using new-generation oral anticoagulants were included in the study. There was no significant difference between the two groups regarding demographic characteristics and laboratory data. The mortality rates for the warfarin and new-generation anticoagulant groups were similar insert ignore into journalissuearticles values(39.1% vs. 43.6%, respectively; p = 0.731);. Also, there was no significant difference in the results of major bleeding and intubation rates between the two groups. Conclusion: There was no difference in the effects of warfarin and new-generation oral anticoagulants on mortality, intubation and major bleeding among the patients with COVID-19.
Keywords : Antikoagülasyon, Covid 19, koronavirüs, tromboz